-+ 0.00%
-+ 0.00%
-+ 0.00%

Allergy Therapeutics Names Chief Strategy Officer as Executive Chair

MT Newswires·07/28/2026 03:06:04
Listen to the news
03:06 AM EDT, 07/28/2026 (MT Newswires) -- Allergy Therapeutics (AGY.L) appointed Chief Strategy Officer Helge Weiner-Trapness as executive chairman to succeed Peter Jensen. The British biotechnology company said Tuesday that Jensen will remain in the company as a nonexecutive director to ensure an orderly handover of responsibilities.